More on INSM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+55.9% Growth)
- Ratings (9.4 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INSM Cash Flow Statement

Click line-items for a historical chart and %
Net (loss) income -107.87M
Depreciation and amortization
Stock based compensation expense 13.88M
Accounts receivable
Income tax receivable
Prepaid expenses and other assets
Accounts payable 361K
Accrued expenses
Deferred revenue
Net cash (used in) provided by operating activities
Purchase of fixed assets -3.43M
Sales of short-term investments
Purchases of short-term investments
Net cash provided by (used in) investing activities
Payments on capital lease obligations
Repayment of convertible notes
Proceeds from issuance of common stock 0
Net cash used in financing activities
Decrease in cash and cash equivalents -82.36M
Cash and cash equivalents at Beginning of period
Cash and cash equivalents at End of period
Unrealized gain on investments
Accretion of beneficial conversion feature
Cash paid for interest 2.47M
Cash paid for taxes, net

Entities mentioned with INSM

View All Entities